| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.04 |